Dr. Richard Burt

Northwestern abruptly ending Burt HSCT autoimmune trials

Selma-Blair-HSCT

“HSCT Chicago Clinic Closing!” is the startling header in all caps on a patient-run Facebook page about a stem cell therapy clinical trial program at Northwestern University. What’s going on? Unfortunately, the promising field of hematopoietic stem cell transplantation (HSCT) for multiple sclerosis (MS) and other autoimmune diseases seems to have suffered an unexpected setback …

Northwestern abruptly ending Burt HSCT autoimmune trials Read More »

Upbeat Burt team pub on stem cells for MS comes with uneasy back story

Types-of-Multiple-Sclerosis

Stem cells for MS? How promising is that? A new paper gives stronger reason for hope, but unfortunately this story is more complex than it seems on first glance. New Paper The idea of using a stem cell-related approach to treat multiple sclerosis (MS) has been around for a long time holding major promise, but …

Upbeat Burt team pub on stem cells for MS comes with uneasy back story Read More »

Burt Northwestern Stem Cell MS Trial Part 3: Funding, Patient Perspectives, & the Future

Stem-cells-for-MS-trial-concerns-e1493137263166

Today’s post is the last of a three-part series on the Burt stem cell trials at Northwestern. This piece is focused on funding and the future of the trial, and also includes perspectives from patients. You can read Part 1 here and Part 2 here, which focused on issues related to potential encouragement of patient fundraising that unintentionally releases …

Burt Northwestern Stem Cell MS Trial Part 3: Funding, Patient Perspectives, & the Future Read More »

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes?

stem-cells-MS-Northwestern-University

Can science now cure MS in some patients with stem cells or is that near on the horizon? What about stem cells for other serious autoimmune disorders? What are the risks to patients in terms of health, money, and hope? What if patients must find $100,000 or $200,000 just to get into a clinical trial for …

Burt Northwestern Stem Cell MS Trial Part 2: Marketing ‘Cure’-Like Outcomes? Read More »

Burt Northwestern Stem Cell MS Trial Part 1: Big Promise & Tough Questions

Curing-Multiple-Sclerosis-Stem-Cells

Dr. Richard Burt of Northwestern University has been doing cutting edge research on the use of stem cells for autoimmune disorders for more than a decade. The core idea behind the work that Burt and other research teams are doing is that stem cells may have revolutionary potential to somehow counteract the autoimmunity that causes …

Burt Northwestern Stem Cell MS Trial Part 1: Big Promise & Tough Questions Read More »

FDA warns Northwestern’s Richard Burt on reporting patient deaths, other issues in stem cell trials

Richard-Burt-Warning-Letter-e1490745772151

The FDA recently issued a lengthy warning letter to Northwestern University over the clinical trial practices of its Dr. Richard Burt and this letter just popped up on the FDA website. To my knowledge this is an unprecedented event as I’m not aware of another warning letter to a major university for a stem cell trial. Burt received the FDA …

FDA warns Northwestern’s Richard Burt on reporting patient deaths, other issues in stem cell trials Read More »

Guest blog from inside Vatican Stem Cell Meeting by John Carbona: Day 1

rome-day-1-b

The Vatican Stem Cell Meeting 2013 has started. We are fortunate to have a guest blogger, John A. Carbona, CEO of BioLife Cell Bank, who is in attendance and kindly is giving us inside coverage of the meeting. Below is a guest blog from John on Day 1 of the meeting. We even have pictures. …

Guest blog from inside Vatican Stem Cell Meeting by John Carbona: Day 1 Read More »